AdvaMed: "Industry should get user fee relief too"
This article was originally published in Clinica
The US medical technology industry association, AdvaMed, has decided that Congress should agree to "forgive" a portion of what industry owes in user fees as part of any legislative fix of the user fee programme.
You may also be interested in...
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.